Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 90.00
0.00 (-1.64%)
Sep 4, 2026, 12:58 PM CST
Acer Medical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 153.77 | 176.15 | 202.78 | 220.03 | 276.56 | 49.68 |
Short-Term Investments | - | 2.5 | - | - | - | 80 |
Cash & Short-Term Investments | 153.77 | 178.65 | 202.78 | 220.03 | 276.56 | 129.68 |
Cash Growth | -15.64% | -11.90% | -7.84% | -20.44% | 113.26% | 199.06% |
Accounts Receivable | 15.65 | 11.45 | 10.74 | 15.29 | 4.56 | 4.09 |
Other Receivables | 1.21 | 1.18 | 1.71 | 2.18 | 1.1 | 0.56 |
Receivables | 16.86 | 12.63 | 12.45 | 17.47 | 5.66 | 4.65 |
Inventory | 4.77 | 5.89 | 3.72 | 12.13 | - | 0.76 |
Prepaid Expenses | 5.89 | 3.24 | 1.95 | 0.22 | 0.46 | 0.85 |
Other Current Assets | - | - | - | 0 | - | - |
Total Current Assets | 181.29 | 200.41 | 220.89 | 249.86 | 282.68 | 135.95 |
Property, Plant & Equipment | 2.3 | 1.93 | 1.82 | 2.39 | 3.12 | 0.44 |
Other Intangible Assets | 5.14 | 3.21 | 3.87 | 4.53 | 4.36 | 0.34 |
Other Long-Term Assets | 2.3 | 1.68 | 0.31 | 2.65 | - | - |
Total Assets | 191.02 | 207.23 | 226.89 | 259.43 | 290.16 | 136.73 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.93 | 2.46 | 1.73 | 8.42 | 0.86 | 0.8 |
Accrued Expenses | 28.85 | 31.98 | 27.38 | 15.44 | 15.96 | 8.48 |
Short-Term Debt | - | 2.5 | - | - | - | - |
Current Unearned Revenue | 1.35 | 1.64 | 0.24 | 0.01 | - | 1.02 |
Other Current Liabilities | 4.12 | 3.72 | 2.96 | 13.62 | 13.22 | 11.65 |
Total Current Liabilities | 35.25 | 42.3 | 32.3 | 37.49 | 30.04 | 21.95 |
Total Liabilities | 35.25 | 42.3 | 32.3 | 37.49 | 30.04 | 21.95 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 152.26 | 152.26 | 152.26 | 152.26 | 152.26 | 120 |
Additional Paid-In Capital | 203.81 | 203.81 | 203.79 | 203.78 | 203.78 | 36 |
Retained Earnings | -200.3 | -191.15 | -161.46 | -134.1 | -95.92 | -41.21 |
Shareholders' Equity | 155.77 | 164.92 | 194.59 | 221.94 | 260.12 | 114.79 |
Total Liabilities & Equity | 191.02 | 207.23 | 226.89 | 259.43 | 290.16 | 136.73 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 2.5 | - | - | - | - |
Net Cash (Debt) | 153.77 | 176.15 | 202.78 | 220.03 | 276.56 | 129.68 |
Net Cash Growth | -15.64% | -13.13% | -7.84% | -20.44% | 113.26% | 199.06% |
Net Cash Per Share | 10.10 | 11.57 | 13.32 | 14.45 | 22.42 | 16.73 |
Filing Date Shares Outstanding | 15.23 | 15.23 | 15.23 | 15.23 | 12.67 | 12 |
Total Common Shares Outstanding | 15.23 | 15.23 | 15.23 | 15.23 | 12.67 | 12 |
Working Capital | 146.04 | 158.11 | 188.59 | 212.37 | 252.64 | 114 |
Book Value Per Share | 10.23 | 10.83 | 12.78 | 14.58 | 20.53 | 9.57 |
Tangible Book Value | 150.64 | 161.71 | 190.72 | 217.4 | 255.76 | 114.45 |
Tangible Book Value Per Share | 9.89 | 10.62 | 12.53 | 14.28 | 20.18 | 9.54 |
Machinery | 4.72 | 4.03 | 3.63 | 3.63 | 3.65 | 0.5 |